Skip to main content
Year archive

PROTEOMICS INTERNATIONAL LABORATORIES LTD — 2018 filings

All 66 regulatory filings released by PROTEOMICS INTERNATIONAL LABORATORIES LTD (PIQ) in 2018, sourced directly from the official regulator.

66 Filings
2018 Period
2018 filings (66)
Filing Released Lang
Exercise of Options - Secondary Trading Notice & Appendix 3B 13 pages 633.0KB
Regulatory Filings
2018-12-02 English
Proteomics signs PromarkerD agreement with US big pharma 3 pages 263.5KB
Regulatory Filings
2018-11-25 English
Proteomics AGM Presentation 27 pages 1.4MB
Regulatory Filings
2018-11-21 English
Results of Meeting 2 pages 503.8KB
Regulatory Filings
2018-11-21 English
Final Director's Interest Notice 2 pages 154.8KB
Regulatory Filings
2018-11-21 English
Appendix 3B - Issue of Director Options and Shares 11 pages 185.1KB
Regulatory Filings
2018-11-21 English
Secondary trading notice 2 pages 196.1KB
Regulatory Filings
2018-11-21 English
Change of directors' interest notices 9 pages 573.8KB
Regulatory Filings
2018-11-21 English
Adelaide Equity & Scintilla Capital appointed as advisors 1
Regulatory Filings
2018-11-13 English
PromarkerD kit version complete- commercial release imminent 3 pages 366.2KB
Regulatory Filings
2018-11-08 English
Appendix 4C - September 2018 Quarterly Report 7 pages 366.7KB
Regulatory Filings
2018-10-29 English
Diabetic kidney disease test enters Europe & Export Award 2 pages 236.1KB
Regulatory Filings
2018-10-23 English
Notice of Annual General Meeting/Proxy Form 25 pages 845.1KB
Regulatory Filings
2018-10-22 English
Proteomics Non-Executive Director Dr Dunlop to retire at AGM 1
Regulatory Filings
2018-10-22 English
Proteomics receives $834k in R&D Tax Incentive 1 pa
Regulatory Filings
2018-10-16 English
Proteomics receives $928k from sale of shareholding in CPR 1
Regulatory Filings
2018-10-04 English
Proteomics & Atturos partner to target diagnostics in Europe 2 pages 260.3KB
Regulatory Filings
2018-09-18 English
Proteomics to receive $928k from sale of shareholding in CPR 1
Regulatory Filings
2018-09-11 English
Corporate Governance Statement and Appendix 4G 29 pages 378.5KB
Regulatory Filings
2018-08-27 English
Preliminary Final Report 19 pages 215.8KB
Regulatory Filings
2018-08-27 English
Annual Report to shareholders 76 pages 9.8MB
Regulatory Filings
2018-08-27 English
Diagnostics update- Pipeline yields potential new biomarkers 3 pages 351.2KB
Regulatory Filings
2018-08-22 English
Appendix 4C - June 2018 Quarterly Report 7 pages 893.9KB
Regulatory Filings
2018-07-29 English
Proteomics secures major contract - nears cash flow positive 2 pages 232.5KB
Regulatory Filings
2018-07-16 English
Further information on new licence deals in USA and Mexico 2 pages 229.1KB
Regulatory Filings
2018-06-20 English
Proteomics signs deal with Patia for PromarkerD in Mexico 3 pages 235.4KB
Regulatory Filings
2018-06-17 English
Proteomics signs deal to launch PromarkerD test in US market 3 pages 250.1KB
Regulatory Filings
2018-05-27 English
Appendix 3B - Issue of Employee Options 9 pages 185.0KB
Regulatory Filings
2018-05-21 English
Appendix 4C - March 2018 Quarterly Report 7 pages 823.3KB
Regulatory Filings
2018-04-25 English
Change of Directors' Interest Notices 4 pages 330.8KB
Regulatory Filings
2018-04-22 English
Europe PromarkerD patent granted for diabetic kidney disease 1
Regulatory Filings
2018-04-18 English
Secondary trading notice 1 page 212.3KB
Regulatory Filings
2018-04-15 English
Appendix 3B 9 pages 384.2KB
Regulatory Filings
2018-04-15 English
Change in substantial holding 2 pages 118.7KB
Regulatory Filings
2018-04-15 English
Change in substantial holding 2 pages 1.5MB
Regulatory Filings
2018-04-15 English
Change in substantial holding 2 pages 11.8MB
Regulatory Filings
2018-04-15 English
Underwriters take final $342,000 of Proteomics Options 2 pages 230.6KB
Regulatory Filings
2018-04-15 English
Secondary trading notice 1 page 214.5KB
Regulatory Filings
2018-04-05 English
Appendix 3B - Exercise of options 9 pages 184.8KB
Regulatory Filings
2018-04-05 English
Change of Director's Interest Notice 3 pages 225.8KB
Regulatory Filings
2018-04-05 English
Conversion of 90% of Proteomics Options raises of $3m 2 pages 230.0KB
Regulatory Filings
2018-04-05 English
Secondary Trading Notice 1 page 154.0KB
Regulatory Filings
2018-03-28 English
Appendix 3B - Exercise of options 9 pages 357.4KB
Regulatory Filings
2018-03-28 English
Change of Director's Interest Notice 3 pages 182.6KB
Regulatory Filings
2018-03-28 English
Secondary Trading Notice 1 page 166.8KB
Regulatory Filings
2018-03-22 English
Appendix 3B - Exercise of options 9 pages 357.3KB
Regulatory Filings
2018-03-22 English
Change of Directors' Interest Notices 14 pages 843.6KB
Regulatory Filings
2018-03-22 English
Directors Exercise PIQ Options 2 pages 229.0KB
Regulatory Filings
2018-03-22 English
Appendix 3B - Expiry of Options 10 pages 490.6KB
Regulatory Filings
2018-03-14 English
Proteomics secures underwriting - PIQ Options to raise $3.4m 2 pages 228.5KB
Regulatory Filings
2018-03-13 English
Appendix 3B 9 pages 362.1KB
Regulatory Filings
2018-03-07 English
Secondary trading notice 1 page 214.5KB
Regulatory Filings
2018-03-07 English
Proteomics launches PromarkerD 2 pages 235.2KB
Regulatory Filings
2018-03-06 English
Secondary trading notice 1 page 162.6KB
Regulatory Filings
2018-03-04 English
Appendix 3B 9 pages 186.7KB
Regulatory Filings
2018-03-04 English
Proteomics completes investment in CPR Pharma Services 1
Regulatory Filings
2018-03-04 English
Expiry of Options - Letter to Option Holders 5 pages 1.2MB
Regulatory Filings
2018-02-18 English
Appendix 4D and Interim Financial Report 22 pages 1.2MB
Regulatory Filings
2018-02-15 English
Appendix 3B 9 pages 371.2KB
Regulatory Filings
2018-02-14 English
Proteomics International Investor Presentation 22 pages 3.9MB
Regulatory Filings
2018-02-06 English
Proteomics International Investor conference call 1
Regulatory Filings
2018-02-05 English
Appendix 3B 9 pages 180.1KB
Regulatory Filings
2018-02-04 English
Proteomics International Options PIQO Exercised 2 pages 217.2KB
Regulatory Filings
2018-02-04 English
Strategic alliance and investment in CPR Pharma Services 3 pages 237.7KB
Regulatory Filings
2018-02-01 English
PromarkerD diabetic kidney disease patent granted in Japan 2 pages 244.0KB
Regulatory Filings
2018-01-28 English
Appendix 4C - December 2017 Quarterly Report 8 pages 340.3KB
Regulatory Filings
2018-01-24 English